Consumer Staples [ 9/12 ] | Consumer Staples Distribution & Retail [ 38/74 ]
NASDAQ | Common Stock
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally.
It operates through three segments:U. S.
Retail Pharmacy, International, andU. S.
Healthcare.
TheU. S.
Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile.
TheU. S.
Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors.
Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 27, 24 | 0.63 Decreased by -37.00% | 0.68 Decreased by -7.35% |
| Mar 28, 24 | 1.20 Increased by +3.45% | 0.82 Increased by +46.34% |
| Jan 4, 24 | 0.66 Decreased by -43.10% | 0.61 Increased by +8.20% |
| Oct 12, 23 | 0.67 Decreased by -16.25% | 0.69 Decreased by -2.90% |
| Jun 27, 23 | 1.00 Increased by +4.17% | 1.07 Decreased by -6.54% |
| Mar 28, 23 | 1.16 Decreased by -27.04% | 1.10 Increased by +5.45% |
| Jan 5, 23 | 1.16 Decreased by -30.95% | 1.14 Increased by +1.75% |
| Oct 13, 22 | 0.80 Decreased by -31.62% | 0.77 Increased by +3.90% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Aug 31, 24 | 37.55 B Increased by +6.00% | -3.00 B Decreased by -1.57 K% | Decreased by -8.00% Decreased by -1.47 K% |
| May 31, 24 | 36.35 B Increased by +2.64% | 344.00 M Increased by +761.54% | Increased by +0.95% Increased by +744.50% |
| Feb 29, 24 | 37.05 B Increased by +6.28% | -5.91 B Decreased by -1.20 K% | Decreased by -15.95% Decreased by -1.14 K% |
| Nov 30, 23 | 36.71 B Increased by +9.96% | -67.00 M Increased by +98.25% | Decreased by -0.18% Increased by +98.41% |
| Aug 31, 23 | 35.42 B Increased by +9.16% | -180.00 M Increased by +65.58% | Decreased by -0.51% Increased by +68.47% |
| May 31, 23 | 35.41 B Increased by +8.64% | -52.00 M Decreased by -117.99% | Decreased by -0.15% Decreased by -116.56% |
| Feb 28, 23 | 34.86 B Increased by +3.28% | 537.00 M Decreased by -39.18% | Increased by +1.54% Decreased by -41.11% |
| Nov 30, 22 | 33.38 B Decreased by -1.53% | -3.82 B Decreased by -206.79% | Decreased by -11.45% Decreased by -208.45% |